Buscar
Mostrando ítems 1-10 de 11
Ranolazine Exerts Potent Effects on Atrial Electrical Properties and Abbreviates Atrial Fibrillation Duration in the Intact Porcine Heart
(WILEY-BLACKWELL PUBLISHING, INC, 2009)
Introduction: In vitro studies and ambulatory ECG recordings from the MERLIN TIMI-36 clinical trial suggest that the novel antianginal agent ranolazine may have the potential to suppress atrial arrhythmias. However, there ...
Intrapericardial Ranolazine Prolongs Atrial Refractory Period and Markedly Reduces Atrial Fibrillation Inducibility in the Intact Porcine Heart
(LIPPINCOTT WILLIAMS & WILKINS, 2010)
Introduction: Extensive experimental studies and clinical evidence (Metabolic Efficiency with Ranzolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction-36 [MERLIN ...
Ranolazine for stable angina pectoris
(Wiley, 2017)
BACKGROUND: Stable angina pectoris is a chronic medical condition with significant impact on mortality and quality of life; it can be macrovascular or microvascular in origin. Ranolazine is a second-line anti-anginal drug ...
Mecanismos Celulares E Moleculares Da Ação Antiarritímica Da Ranolazina Na Síndrome Do Qt Longo Do Tipo 3
(Universidade Federal de São Paulo (UNIFESP), 2018-10-25)
The Contractile Function Of The Heart Depends On The Proper Generation And Propagation Of The Electrical Signal By The Organ. Alterations In This Process Contribute To The Formation Of Cardiac Arrhythmias, Taking As An ...
Energy Metabolism in Cardiac Remodeling and Heart Failure
(2013-05-01)
Fatty acids are the main substrates used by mitochondria to provide myocardial energy under normal conditions. During heart remodeling, however, the fuel preference switches to glucose. In the earlier stages of cardiac ...
Energy Metabolism in Cardiac Remodeling and Heart Failure
(2013-05-01)
Fatty acids are the main substrates used by mitochondria to provide myocardial energy under normal conditions. During heart remodeling, however, the fuel preference switches to glucose. In the earlier stages of cardiac ...
Nuevos enfoques farmacológicos en el manejo de la angina de pecho estable
ABSTRACT In recent years, new antianginal agents with novel mechanisms of action have been launched to the market, as a complement to the existing therapeutic arsenal. Even though the beta-blockers, calcium channel blockers ...
Heart failure with preserved fjection fraction: overview and perioperative managementFalla cardiaca con fracción de eyección preservada: generalidades y aproximación en el perioperatorioFalência cardíaca com fração de ejeção preservada: generalidades e abordagens no perioperatório
(Universidad Militar Nueva Granada, 2021)